Tilray Brands (NASDAQ: TLRY) has been trading sideways in recent weeks, with the stock hovering around $6.90 after a steep decline from its December 2024 high of $15.65. Despite a 70% drop from that peak, technical analysis suggests the cannabis company may be on the verge of a significant rebound.
Technical Setup Points to Potential Breakout
The daily chart reveals a falling wedge pattern, characterized by two descending and converging trendlines. This formation often precedes a bullish breakout, especially as the lines near their confluence. Additionally, a tiny inverted head-and-shoulders pattern has emerged, reinforcing the possibility of an upward move. If the breakout materializes, TLRY could target the $10 resistance level, representing a roughly 45% gain from current prices.
However, the stock remains below the 50-day and 100-day exponential moving averages, and it has slipped under the key support level at $7.0, which was its lowest point in December 2024. The 78.6% Fibonacci retracement level has also been breached, indicating that the path to recovery may face headwinds.
Regulatory Uncertainty Weighs on Sentiment
The broader cannabis sector has lost momentum as President Donald Trump has yet to address the cannabis reclassification process he announced last year. Investors are concerned that the rescheduling may face delays or opposition, which would be a setback for Tilray's U.S. expansion plans. A reclassification would allow the company to operate more freely in the American market, a key growth driver.
Operational Improvements Offer Some Support
Despite the regulatory overhang, Tilray's underlying business has shown resilience. In the most recent quarter, revenue rose 11% year-over-year to a record $206.7 million, marking the second consecutive quarter of double-digit growth. The core cannabis segment led the way with a 19% increase to $64.8 million, while the wellness business grew 16% to $16.4 million, with gross margins improving to 33%.
International operations were a standout, with revenue surging 73% in the last quarter. However, some investors remain cautious, as much of the growth has been fueled by acquisitions. The distribution segment contributed over $83 million, but beverage revenue fell to $42.6 million from $55.9 million in the prior year, despite significant investment in beverage brands.
Management has guided for EBITDA between $62 million and $72 million for the full year. The company's Project 420 cost-cutting initiative is expected to save over $33 million annually, which helped narrow the net loss by 97% to $793,000 in the third quarter. Tilray also reduced its debt by $4.2 million and ended the quarter with more than $264 million in cash and short-term investments.
Outlook and Risks
While the technical patterns suggest a potential rally, the stock faces significant risks, including regulatory delays, declining beverage revenue, and reliance on acquisitions for growth. Investors should weigh these factors against the company's improving profitability and strong balance sheet.
For broader market context, see how Dow Surges 384 Points as Semiconductor Rebound Powers Wall Street Ahead of Big Tech Earnings and Coinbase Surges on 'Everything Exchange' Expansion and Regulatory Wins.
This article is for informational purposes only and does not constitute financial advice.
